Intervention not reported
escitalopram:desvenlafaxine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
escitalopram:duloxetine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
fluoxetine:citalopram · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
escitalopram:fluoxetine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
mirtazapine:escitalopram · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
escitalopram:paroxetine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
escitalopram:sertraline · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
escitalopram:venlafaxine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Intervention not reported
mirtazapine:citalopram · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
escitalopram:vilazodone · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
escitalopram:vortioxetine · children and/or adolescents with depression
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Healthcare utilisation · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health outcomes · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
CI: Confidence interval · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Drug use · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Drug prices · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Drug expenditure · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Failure to respond at endpoint (6‐12 weeks) · patients with depression
Paroxetine probably leads to higher failure to respond at endpoint (6‐12 weeks) compared with citalopram (moderate certainty).
1 finding from 1 review
Failure to respond at 1‐4 weeks · patients with depression
1 finding from 1 review